Davenport & Co’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
Davenport & Co's GMAB Position: Q3 2026 in Review
Davenport & Co reduced its Genmab (GMAB) stake by 2.4% in Q3 2026, selling an estimated $32.4K and leaving 41,520 shares worth $1.48M. The position accounts for 0.01% of the portfolio, ranked #649.
Davenport & Co first reported a position in GMAB in Q2 2021 and has held it in 20 quarters since. 204 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.
- Davenport & Co held 41,520 shares of Genmab worth $1.48M as of Q3 2026.
- Davenport & Co sold 1,024 Genmab shares in Q3 2026, an estimated $32.4K.
- Genmab made up 0.01% of Davenport & Co's portfolio in Q3 2026, its #649 holding.
- Davenport & Co first reported a position in Genmab in Q2 2021 and has held it in 20 quarters since.
- 204 funds tracked by Wall St. Rank held Genmab as of Q3 2026.
Based on Davenport & Co's 13F filing for Q3 2026, filed 14 Oct 2026.